On November 27, 2018 Eli Lilly and Company (NYSE:LLY) reported that it will host a meeting for the investment community on Wednesday, December 19, 2018, from 9:00 a.m. (EST) until approximately 12:00 p.m (Press release, Eli Lilly, NOV 27, 2018, View Source [SID1234531672]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Earlier that day, the company will announce its financial guidance for 2019. At the investment community meeting, Lilly leadership will further detail the 2019 financial guidance and discuss progress towards the company’s strategic goals, as well as the commercial performance of recently launched medicines. A substantial portion of the meeting will then focus on Lilly’s research and development opportunities in the areas of oncology, pain, neurodegeneration, immunology and diabetes.

Meeting attendees will include institutional investors, sell-side analysts, ratings agency representatives, and financial and business media. Because of limited space, advance registration is required and in-person attendance is by invitation only. A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly’s Investor website at View Source A replay of the presentation will be available on this same website for approximately 90 days.